(Q54125651)

25 May 2018

title

Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats. (English)

1 reference

25 May 2018

1 reference

P Sogni

1

1 reference

25 May 2018

R Moreau

2

1 reference

25 May 2018

A Gomola

3

1 reference

25 May 2018

A Gadano

4

1 reference

25 May 2018

S Cailmail

5

1 reference

25 May 2018

Y Calmus

6

1 reference

25 May 2018

M Clozel

7

1 reference

25 May 2018

D Lebrec

8

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 September 1998

1 reference

25 May 2018

published in

Hepatology

1 reference

25 May 2018

volume

28

1 reference

25 May 2018

issue

3

1 reference

25 May 2018

page(s)

655-659

1 reference

25 May 2018

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Circulating levels of endothelin in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Elevated circulating plasma endothelin-1 concentrations in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Clinical significance of plasma endothelin-1 in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Effects of endothelin in portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

17 beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Endothelin-1 induces liver vasoconstriction through both ETA and ETB receptors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Endothelin-induced vasoconstriction in isolated perfused liver preparations from normal and cirrhotic rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Effects of bosentan (Ro 47-0203), an ETA-, ETB-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

200 years of digitalis: the emerging central role of the sodium ion in the control of cardiac force

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Effect of vasodilators on hepatic microcirculation in cirrhosis: a study in the isolated perfused rat liver.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Venous smooth muscle contains vasoconstrictor ETB-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Functional role of endothelin ETA and ETB receptors in venous and arterial smooth muscle

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Bosentan improves renal regional blood flow in rats with experimental congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Cirrhotic cardiomyopathy: getting to the heart of the matter

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280308

7 January 2021

Identifiers

DOI

10.1002/HEP.510280308

1 reference

25 May 2018

1 reference

25 May 2018